Unknown

Dataset Information

0

Truncating Homozygous Mutation of Carboxypeptidase E (CPE) in a Morbidly Obese Female with Type 2 Diabetes Mellitus, Intellectual Disability and Hypogonadotrophic Hypogonadism.

ABSTRACT: Carboxypeptidase E is a peptide processing enzyme, involved in cleaving numerous peptide precursors, including neuropeptides and hormones involved in appetite control and glucose metabolism. Exome sequencing of a morbidly obese female from a consanguineous family revealed homozygosity for a truncating mutation of the CPE gene (c.76_98del; p.E26RfsX68). Analysis detected no CPE expression in whole blood-derived RNA from the proband, consistent with nonsense-mediated decay. The morbid obesity, intellectual disability, abnormal glucose homeostasis and hypogonadotrophic hypogonadism seen in this individual recapitulates phenotypes in the previously described fat/fat and Cpe knockout mouse models, evidencing the importance of this peptide/hormone-processing enzyme in regulating body weight, metabolism, and brain and reproductive function in humans.

SUBMITTER: Alsters SI 

PROVIDER: S-EPMC4485893 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Truncating Homozygous Mutation of Carboxypeptidase E (CPE) in a Morbidly Obese Female with Type 2 Diabetes Mellitus, Intellectual Disability and Hypogonadotrophic Hypogonadism.

Alsters Suzanne I M SI   Goldstone Anthony P AP   Buxton Jessica L JL   Zekavati Anna A   Sosinsky Alona A   Yiorkas Andrianos M AM   Holder Susan S   Klaber Robert E RE   Bridges Nicola N   van Haelst Mieke M MM   le Roux Carel W CW   Walley Andrew J AJ   Walters Robin G RG   Mueller Michael M   Blakemore Alexandra I F AI  

PloS one 20150629 6

Carboxypeptidase E is a peptide processing enzyme, involved in cleaving numerous peptide precursors, including neuropeptides and hormones involved in appetite control and glucose metabolism. Exome sequencing of a morbidly obese female from a consanguineous family revealed homozygosity for a truncating mutation of the CPE gene (c.76_98del; p.E26RfsX68). Analysis detected no CPE expression in whole blood-derived RNA from the proband, consistent with nonsense-mediated decay. The morbid obesity, int  ...[more]

Similar Datasets

Unknown POGZ truncating alleles cause syndromic intellectual disability.
| S-EPMC4702300 | biostudies-literature
Unknown A Novel LINS1 Truncating Mutation in Autosomal Recessive Nonsyndromic Intellectual Disability.
| S-EPMC7247441 | biostudies-literature
Unknown De Novo Truncating Mutations in WASF1 Cause Intellectual Disability with Seizures.
| S-EPMC6037130 | biostudies-literature
Unknown Expanding the phenotype of IQSEC2 mutations: truncating mutations in severe intellectual disability.
| S-EPMC3895633 | biostudies-literature
Unknown De novo truncating variants in PHF21A cause intellectual disability and craniofacial anomalies.
| S-EPMC6460561 | biostudies-literature
Unknown Intellectual disability associated with a homozygous missense mutation in THOC6.
| S-EPMC3644499 | biostudies-literature
Unknown Homozygous ARHGEF2 mutation causes intellectual disability and midbrain-hindbrain malformation.
| S-EPMC5428974 | biostudies-literature
Unknown Homozygous deletion of Tenascin-R in a patient with intellectual disability.
| S-EPMC3395313 | biostudies-literature
Unknown Syndromic Intellectual Disability Caused by a Novel Truncating Variant in AHDC1: A Case Report.
| S-EPMC6525729 | biostudies-literature
Unknown A truncating mutation of TRAPPC9 is associated with autosomal-recessive intellectual disability and postnatal microcephaly.
| S-EPMC2790576 | biostudies-literature